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ABSTRACT Objective: Intradialytic haemodynamic instability is a significant clinical problem, leading to
end-organ ischaemia and contributing to morbidity and mortality in haemodialysis patients. Non-invasive
continuous blood pressure monitoring is not currently part of routine practice but may aid detection and
prevention of significant falls in blood pressure during dialysis. Brachial blood pressure is currently recorded
intermittently during haemodialysis via a sphygmomanometer. Current methods of continuous non-invasive
blood pressure monitoring tend to restrict movement, can be sensitive to external disturbances and patient
movement, and can be uncomfortable for the wearer. Additionally, poor patient blood circulation can lead to
unreliable measurements. In this feasibility study we performed an initial validation of a novel method and
associated technology to continuously estimate blood pressure using pressure sensors in the extra-corporeal
dialysis circuit, which does not require any direct contact with the person receiving dialysis treatment.
Method: The paper describes the development of the measurement system and subsequent in vivo patient
feasibility study with concurrent measurement validation by Finapres Nova physiological measurement
device. Real-time physiological data is collected over the entire period of (typically 4-hour) dialysis treatment.
Results: We identify a quasi-linear mathematical function to describe the relationship between arterial line
pressure and brachial artery BP, which is confirmed in a patient study. The results from this observational
study suggest that it is feasible to derive a continuous measurement of brachial pressure from continuous
measurements of arterial and venous line pressures via an empirically based and updatedmathematical model.
Conclusion: The methodology presented requires no interfacing to proprietary dialysis machine systems,
no sensors to be attached to the patient directly, and is robust to patient movement during treatment and
also to the effects of the cyclical pressure waveforms induced by the hemodialysis peristaltic blood pump.
This represents a key enabling factor to the development of a practical continuous blood pressure monitoring
device for dialysis patients.
INDEX TERMS Blood pressure measurement, extracorporeal pressure sensors, fistula, hemodialysis, con-
tinuous blood pressure measurement.
I. INTRODUCTION
Patients receiving hemodialysis treatment as a result of
end-stage kidney disease (ESKD) are at a much higher risk
of mortality due to cardiovascular disease (CVD) [1]. A
key factor contributing to CVD is intradialytic hypotension,
a frequent complication affecting 15% − 50% of treatments
which is associated with subsequent vascular access throm-
bosis, inadequate dialysis dose, cardiac dysfunction and mor-
tality. The continuous monitoring of blood pressure (BP)
during dialysis, particularly with respect to early detection
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and prediction of hypotension [2] has the potential to signifi-
cantly improve patient outcomes [3]–[5] and could ultimately
inform the choice of therapeutic intervention via modulation
of dialysis time and/or duration, dialysate sodium concentra-
tion and/or temperature on a per patient basis.
Intradialytic hypotension (IDH) is a sudden event, and
generally defined as a decrease in systolic blood pressure
greater than 20 mmHg or a decrease in mean arterial pressure
by 10mmHg [6]. Associated symptoms can include dizziness
or fainting, anxiety, muscle cramps, abdominal discomfort,
nausea and vomiting. In addition to the negative impact
on patient well-being, IDH can result in truncated dialysis
treatments and increase the risk for coronary and cerebral
ischemic incidents. IDH prediction, detection and mitiga-
tion is ultimately the primary application area of the work
described in this article. Continuous monitoring of blood
pressure (BP) during dialysis could ultimately inform the
formulation of a treatment regime, or close a personalised
therapeutic intervention loop via modulation of dialysis time
and/or duration, dialysate sodium concentration and/or tem-
perature on a per patient basis.
Arterial cannulation is widely regarded as the gold stan-
dard reference for continuousmeasurement of BP [7], (which
is referenced to brachial artery BP in common with all
the methods discussed here). While a common procedure
during high-risk surgery, it is not considered appropriate
for haemodialysis patients where non-invasive monitoring is
indicated. This is normally achieved in a clinical setting via
the use of an air-filled occluding arm cuff that provides a
robust, but intermittent measurement that disrupts the normal
blood flow, and so requires a significant settling time between
measurements [8].
Three distinct methods for non-invasive monitoring of BP
have occasionally been used in research settings. The first
of these is arterial applanation tonometry [9] where a trans-
ducer is positioned above a superficial artery compressing it
against an underlying bone. Analysis of the resulting pulse
wave has been extended to calculate systolic and diastolic
pressure [10]. This method has been used in cardiology and
anaesthetised procedures to avoid the insertion of an arterial
cannula [11], [12], but as these devices are hand-held and
are operator-dependent, they are unsuitable for continuous
monitoring.
The secondmethod for non-invasive continuous estimation
of BP is Pulse Transition Time (PTT) [13] which is based
on measured photoplestimography (PPG) and electrocardio-
gram (ECG) signals during several cardiac cycles. PTT is then
calculated as the time difference between the ‘R’ peak in the
ECG signal and the corresponding time instance of the inflec-
tion point on the maximum slope of the PPG signal. This
method may not be accurate due in part to the unaccounted
physiological factors in the blood regulation mechanism and
reliance on accurate ECG triggering [14].
The third alternative is the volume clamp (or vascular
unloading) method [8] where an inflatable finger-cuff com-
bined with an embedded photodiode measures the diameter
of the finger artery. Cuff pressure is adjusted to maintain a
constant artery diameter, and the changes in cuff pressure are
used to calculate a BP curve in the brachial artery. In use,
patients frequently report pain or discomfort at the fingertips
where cuffs are placed, and this device can be unreliable in
patients with reduced blood flow to the digits, for example,
dialysis patients [13]. All three non-invasive methods are sen-
sitive to patient movement (especially PPG based methods)
[15] which would result in an unacceptable and uncomfort-
able restriction placed on patients during a four-hour dialysis
treatment.
A. THE iTrend RENAL DIALYSIS PROGRAMME
The iTrend (Intelligent Technologies for Renal Dialysis) pro-
gramme is a long-term collaborative project performed by
a multidisciplinary research team from the Universities of
Derby and Nottingham and the Royal Derby Hospital Renal
Unit in the UK. The primary goal of the programme is to
develop supporting technologies and real-time analysis of
data to enable personalised and precision treatment in ESKD
[16], [17]. Blood pressure monitoring to diagnose hyperten-
sion and hypotension [18], [19] are typically plethorperidi-
alytic and intermittent intradialytic BP measurements. The
ability to continuously monitor BP both in terms of absolute
measures and blood pressure variability could lead to new
diagnostic and prognostic criteria for IDH as well as optimal
and personalised treatment strategies.
In this work, a feasibility study based around a novel
method for continuously monitoring BP is described which
involves the placement of pressure transducers onto the
venous and arterial blood lines that connect a patient to a
haemodialysis machine during treatment. This study is the
first step to develop a continuous blood pressure estimat-
ing/measuring device for dialysis treatment. The resulting
data is compared against standard BPmeasurements obtained
via an occluding arm cuff and the volume clamp method, via
the Finapres Nova (FMS, Finapres Measurement Systems,
Arnhem, Netherlands), whose accuracy has been studied [9],
[10] and validated according to the recent British Hyperten-
sion Society protocol and the criteria of the Association for
the Advancement of Medical Instrumentation. Only the inter-
mittent cuff pressured recorded by Finapres Nova is utilised
in the present manuscript
B. STRUCTURE OF THIS ARTICLE
This article describes the development of a continuous,
non-invasive method to measure BP during renal dialysis
sessions. Design objectives were as follows:
• to provide reliable and robust measurement of patient
blood pressure before, during and immediately after
haemodialysis treatment;
• with regards to patient experience, to require no extra-
neous sensors to be attached directly to the patient;
• the measurement method to be robust to patient move-
ment during treatment;
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• the sensors to be cost-effective, non-bespoke and readily
available as off the shelf items;
• data aquisition and analysis hardware to be low physical
footprint and low cost;
• the system should not require any special interfaces
to and should work equally well with any proprietary
dialysis machine.
The paper is divided into the following sections:
• Section II: A generalised parameterisedmodel is derived
to describe the approximate relationship between mea-
sured brachial cuff pressure measurements and arte-
rial line pressure measurements during hemodialysis
treatment.
• Section III: The feasibility study data acquisition system
and associated hardware is described along with exper-
imental study participants and the dialysis bay experi-
mental setup.
• Section IV: Results from the experimental feasibility
study are graphically displayed and analysed.
• Section V: Conclusions derived from the study are pre-
sented, and future work described.
For clarity, where a patient’s BP is mentioned, this should
be taken to mean brachial blood pressure.
II. CONTINUOUS, NON-INVASIVE INTRADIALYTIC BP
MEASUREMENT FROM DIALYSIS LINES
The use of pressure signals from the arterial and venous blood
lines of a dialysis machine has been shown in principle to
enable continuous online monitoring of a patient’s heart rate,
even for patients with low cardiac signal amplitude [20], [21].
The method has been extended to monitor ventricular prema-
ture beats [22]. Performance was studied for one dialysis flow
rate (400 ml/min), and results lacked fidelity where patient
heart rate and haemodialysis pump speed coincide. While
promising, the method generated to a number of false positive
and false negative predictions of IDH.
Our approach demonstrates a more robust approach to
derive continuous BP signals from the arterial and venous
dialysis lines and presents the initial results of its in-vivo
verification via on-going patient studies in the Renal Unit at
Royal Derby hospital.
A. METHOD
The aim of this feasibility study is to identify and experimen-
tally derive relationships between the patient’s brachial BP,
and the pressures recorded within the extra-corporeal blood
lines to and from the dialysis machine. Typically, two such
blood lines are provided during haemodialysis: an arterial line
conducts blood from the patient to the dialysis machine, and
a venous line that conducts blood from the dialysis machine
back to the patient. Vascular access to the patient is provided
by means of two large gauge needles (one on each line) into
the patients ‘fistula’, a surgically enlarged blood vessel result-
ing from the connection of a vein onto an artery, typically
located within the patients non-dominant arm.
In order to develop a non-hardware specific generalised
solution to the problem, additional pressure sensors were
placed into the blood lines rather than making use of the
pressure sensors present within the dialysis machines (as in
previous studies). The primary function of these safety criti-
cal machine sensors is setup monitoring. This study utilised
the existing ports and connection points which are common
and standardised on most dialysis blood lines sets (Fig 1).
Starting on the blood return side (Fig. 1) venous blood line
provides a standard 4mm line connection point on the air trap,
which was chosen as the site for the additional venous line
pressure sensor. This is typically the final port on the venous
side (Fig. 2).
As will be seen, the blood flow rate through the
extra-corporeal system is critical to analysis of the rela-
tionship between brachial and arterial line blood pressure
measurements. A real-time measurement of blood flow is
required for the calculations necessary for BP estimation.
Flow rate is generally set at the beginning of treatment,
and recorded manually. For various clinical reasons, medical
professionals may adjust the flow rate during treatment which
may or may not be recorded in patient notes.
The pressure waveform measured by the pressure sensor
connected to the venous bubble trap is dominated by the
oscillations introduced by the lobes of the peristaltic blood
pump [23]. The periodic pressure waveform of such pumps
results from alternative compression and relaxation of the
dialysis line (typically 8 mm diameter at the pump) by the
(typically 2) lobes of the pump. Hence the pump frequency
can be derived from a real-time positive pressure sensor sited
in the venous air trap by the application of Fourier analysis.
By this method, any reasonably well-behaved function can be
written in terms of trigonometric or exponential functions.
Considering a function f (x) that is periodic on the interval
0 ≤ x ≤ L, Fourier’s theorem states that f (x) can be written
as the Fourier trigonometric series for the function as;















As 2π is included in the arguments of the trigonometric
functions, then the n = 1 terms have period L, the n = 2
terms have period L/2, etc. for higher harmonics. For any
integer n, an integral number of oscillations fit into the
period L. In the case under examination here, the fundamental
frequency of the blood pump is sought, so calculations are
conducted for n = 1.
The pump frequency is calculated and updated in real-time
over a sliding window of data which is 5000 samples or 5 s
wide. As the pump frequency is typically around 1 Hz, this
ensures sufficient data, without including dynamics, so effec-
tively a quasi steady-state measurement. Frequency is con-
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FIGURE 1. Sensor and data acquisition signal flow.
FIGURE 2. Pressure sensor connection to venous air trap port.
where fl is flow inmls−1, fr is pump frequency in rads−1, r is
the radius of the dialysis line within the pump inmm and Ln is
the effective length of line within the pump in mm. Brachial
pressure is regularly measured via inflatable cuff, and data
for all the sensors is synchronised and stored via a National
Instruments data acquisition device.
The additional pressure sensor on the arterial-line should
be sited as close as possible to the patient’s vascular access,
since the needle sits between positive pulsatile patient blood
pressure at one end, and blood-pump dominated negative
pulsatile pressure at the other end. Given that no suitable
connector exists at the arterial needle end of the line, a ‘Y’
connector with 4 mm internal diameter is fitted to the tubing
of the dialysis needle to allow access to both the dialysis line
and the arterial line pressure sensor (Fig. 3).
Modelling the relationship between arterial-line pressure
and brachial pressure is extremely complex with high lev-
els of physiological differences between patients. In order
to produce a tractable model, a number of approximations
are included. The brachial cuff measurement is, in effect,
a quasi-steady state measurement single-instance sample of
systolic and diastolic pressure including no dynamic infor-
mation, and hence the arterial line pressure is filtered by
5000 samples moving-average window, similar to the filter
applied to the venous-line pressure data. With reference to
Fig 4, datum point 1 is defined as the tip of the arterial
line needle, and associate pressure P1 and area A1 with it.
Similarly, datum point 2 is defined at the pressure sensor, and
associate pressure P2 and area A2 with it.
Assuming steady, incompressible flow with negligible
losses, blood flow rate can be expressed using Bernoulli and
Continuity equations [26] as;
f = A2












where f is fluid flow and R is the fluid density.
A number of assumptions are inherent in this model; hor-
izontal flow and fully developed flow at P1 and P2, density
and viscosity are constant wrt time. However, many, if not
all, of these assumptions are either unmeasurable, or vary in
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FIGURE 3. Arterial line pressure sensor connector.
FIGURE 4. Arterial line and needle pressure datum points.
practice from patient to patient, or are time-varying during
treatment. Additionally, the temporal and physical distance
between the fistula needle site and the measurement site at the
brachial cuff (typically on the opposite arm to the fistula) is
significant (1̃m). Even for well defined problems, theoretical
flow f is generally 2% − 40% lower than empirical due to
geometry. Therefore, (3) is modified as
f = A2
[





where C is an experimentally determined lumped-parameter
which approximates the unknown and unmodelled features
of the system and the unmet assumptions of the analysis. The
lumped parameter inherently includes the effect of different
dialysis procedural details such as the needle gauge size
that may be used with different patients, and blood pump
flow-rate according to different treatment prescriptions. Indi-
vidual patient-specific parameters such as blood viscosity,
density and temperature are also implicit. Rearranging for C
C =




the expression allows computation of C from measured val-
ues. Assuming P2 represents measured arterial line pressure
as before, and the lumped unknown parameters coefficient C
includes the unknown relationship between P1 and measured
brachial pressure Pb, then a quasi-linear relationship between
arterial line pressure and brachial pressure can be derived
from equation (5), if and only if the unknowns represented
by the variable C are accurately modelled and time-invariant.






C − Pb (6)
where C defines the gradient of the relationship and can
subsequently be used as a predictor between measured P2
and estimated Pb. Given the expectation that C will contain
time varying and unmodelled terms, it can be predicted that
there will be variation around the mean for individual patient
measurements. Future and continuing work may identify a
more accurate description of the system, however the linear
model derived here and presented in the study data confirms
the feasibility of the approach.
III. EXPERIMENTAL HARDWARE
Low-cost industrial process control pressure sensors with
on-board signal amplification and linearization (Honeywell
40PC015V2A 0 PSI to −15 PSI Arterial line, and Honey-
well 40PC015G1A 0 PSI to 15 PSI Venous line) have been
integrated (Fig 11) with connectors to fit ports on standard
dialysis lines. The connectors consist of a 4 mm internal
diameter line, a pressure transducer protector which keeps the
blood side of the circuit separated from the sensor, preventing
patient cross contamination with blood borne pathogens via
a 0.2 micron filter. There is also a bespoke membrane barrier
(Fig. 3) fitted as an extra safety precaution. [24], [25]
Real-time data acquisition (DAQ) and storage is performed
via a National Instruments NI USB-6210,2 16 input 16-bit,
250 kS/s multifunction I/O device. All acquisition is ana-
logue, sampled at 1 kHz on each line. Analogue input lines
operate in the range 0 to 5 V . Data from the Finapres Nova is
transferred to the National Instruments device via dedicated
1after: https://commons.wikimedia.org/wiki/File:Hemodialysis-en.svg
2https://www.ni.com/pdf/manuals/375194d.pdf
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multicore cable. The following Finapres Nova analogue out-
put lines were acquired by the DAQ hardware:
• Reconstructed systolic pressure
• Reconstructed diastolic pressure
• Finger arterial pressure
• ECG II waveform
• Reconstituted brachial arterial pressure
• Brachial arm-cuff measurements
Additionally the venous air trap pressure sensor and arterial
line pressure sensor are connected via dedicated shielded
cables, which include +5 V and 0 V supplies to power the
sensors from the acquisition device. All data streams are time
synchronised via a common real-time clock.
A. EXPERIMENTAL STUDY
Method: Participants >18 years were recruited from the
prevalent dialysis population at Derby Royal Hospital.
Patient’s demographics, dialysis background, dialysis pre-
scription, laboratory parameters pre- and post-dialysis at
each session were recorded. All participants had continuous
non-invasivemonitoring of haemodynamics using pulsewave
analysis (Finapres NOVA) during a single dialysis treatment
of typically 4 hours duration, and this data was periodically
verified by intermittent arm-cuff measurements. Two pres-
sure sensors were attached to the dialysis lines as described:
one between the arterial dialysis needle and dialysis line and
the other directly onto the venous-line bubble trap. Data was
continuously recorded from all sensors at a sampling rate
of 1 kHz.
The study protocol was approved by the West Midlands -
Coventry and Warwickshire Research Ethics Committee and
participants gave written informed consent.
IV. RESULTS
In total 12 participants were recruited with 11 completed
monitored dialysis sessions. 1 participant moved out of area
before a session could be completed. 58.3% of participants
were male, with a median age of 65 (IQR 48-78).
Serial brachial cuff blood pressure values were compared
with synchronous pressure sensor data in Matlab (ver. 19b).
Arterial line pressure sensor data was analysed for dialysis
pump flow by fitting a Fourier model to the continuous
venous line pressure signal. Derived pump flow, arterial and
venous line pressures, and brachial cuff pressure measure-
ments for a typical treatment session are shown in Fig. 5.
Values from the brachial arm cuff (Systolic, Diastolic and
MAP) are saved to a master record with synchronised time
stamps for comparison with the corresponding venous and
arterial line pressures. This master record for the patient study
enables the calculation of lumped parameter C .
In this example (Fig. 5), the dialysis blood pump is enabled
at 2000 s resulting in divergence of the arterial (−ve) and
venous (+ve) line pressures. Subsequently, the Fourier model
outputs a flow rate of 325 ml/min which remains con-
stant for the duration of the treatment, and agrees with the
FIGURE 5. Typical data output for 4-hour treatment session.
patient record. Brachial cuff BPmeasurements are taken from
approximately 30 minutes before the start of treatment and
repeated approximately every 30 minutes throughout. The
cuff measurements of systolic and diastolic BP and MAP are
recorded via the DAQ system with a corresponding value for
blood flow and for arterial pressure. In this case, it is possible
to construct a table of 8 measurements for this treatment, and
a master data set can thus be constructed for the 11 completed
dialysis sessions which allows an analysis to be conducted
against a varied participant population.
In the Renal Unit at Royal Derby Hospital, where the
patient studies are conducted, 14g is the standard and pre-
ferred gauge size for dialysis patients. Smaller diameter
(larger gauge size) needles are used for new patients with
recent fistula, and also for patients with needling prob-
lems.The gauge sizes used during this patient study are:
• 14: 14g Arterial 14g Venous
• 15: 15g Arterial 15g Venous
• 16: 15g Arterial 16g Venous
where 14 is the normal gauge set, and 15, 16 used for new
patients and access issues.
With reference to Fig. 6, C values are calculated for every
measurement set in each treatment, and grouped according
to patient’s needle gauge sizes, which shows the fundamental
effect of needle gauge size on the relationship betweenPb and
P2 measurements. Fig. 6 also illustrates a number of salient
features. In particular, a relatively tight core grouping of C
values for each needle size set (14: 5 − 7, 15: 8 − 9, 16:
9.5− 11). A rising mean of this core grouping (6, 8.5, 10.25)
indicates the influence of the reducing available area on the
difference between Pb and P2. As expected, Fig. 6 shows a
number of outlying measurements. In particular for needle
gauge size 16, the outliers are all from a patient with a
relatively new arteriovenous fistulae (AVF), and may indicate
that maturation of the blood vessel is not complete [27].
For all gauges, it is salient that the coefficient C describes
a range of linear and nonlinear unmodelled effects beyond
needle gauge size andwould be expected to contain outliers in
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FIGURE 6. Values of C associated with Arterial and Venous needle sizes.
a physiologically non-homogenous patient study population
and can additionally contain time varying effects experienced
over the duration of a 4 hour treatment session. With respect
to venous needle gauges in the study, there were 5 cases with
14g, 3 cases with 15g and 2 cases with 16g. The relationship
to, and deviation from the mean value of C wrt needle gauge
is of interest and will be investigated in further studies.
The experimental relationship between brachial cuff MAP
and corresponding measured arterial line pressure for 11 ses-
sions in the patient study is shown in Fig. 7. A linear least
squares fit of y = 0.8x − 1.5 ∗ 102, Root Mean Squares
Error 10.3, R2 0.615, p-value 6.35 ∗ 10−20. As predicted,
the figure displays a correlated scatter for the population
around a linear least squares fit with a gradient which rep-
resents a fundamental relationship between Pb and P2. This
is common to all members of the study, and hence is strongly
associated with the physical components of the dialysis pro-
cedure (pump, pump speed, dialysis line set), with variance
from the line dominated by unmodelled physiological effects.
This is a significant outcome for the project, as it means
that the process of real-time prediction can be decomposed
into two separate functions. Namely, updating the machine
mean relationship to take account of any hardware variances
between machine sets (new machine and or lines can be
modelled into a library), and learning the relationship to the
machine line on a per patient basis (which again can be an
updateable model).
In order to further examine this hypothesis, it is possible
to negate the time varying effects in the data by taking a
mean value for C for each individual patient treatment, and
recalculating the data scatter. This should reduce data vari-
ance since the scatter around the least squares fit line consists
of two components: time varying effects, and unmodelled
physiological effects, and also to a certain extent negate the
time varying effects in the data by taking a mean value for C
for each individual patient treatment, and recalculate the data
scatter. This is shown in Fig. 8. A linear least squares fit of y =
0.82x − 1.5 ∗ 102, Root Mean Squares Error 6.54, R2 0.852,
p-value 2.93 ∗ 10−38. There are a number of salient features
FIGURE 7. Brachial cuff MAP vs Arterial line pressures in 11 patient
sessions (o) with least squares linear fit (+).
FIGURE 8. Brachial cuff MAP vs Arterial line pressures in 11 patient
sessions (o) with least squares linear fit (+) following compensation for
time varying effects during treatment.
in this plot. Firstly, the gradient of the fit has only changed by
2.5% indicating a relatively accurate model for the machine
and lines system. Secondly, the data R2 value has risen
by 38.5% to 0.852, indicating that a tractable and useable
time-invariant model can be constructed. The flow estima-
tor calculations corresponded with dialysis machine settings
within the band +/ − 1%. The patients under observation
within this study all received constant flow rate throughout
individual treatments (cf Fig. 5). However, the range of flow
rates across the patients in the study was 278− 394 ml/min,
which was identified by the estimator in each case contribut-
ing to the level of accuracy shown in Fig. 8. Flow changes
during treatment will be built into the next planned patient
study.
Finally, although the majority of physical systems can
be modelled adequately by linear, time-invariant models,
there is much to be gained in future work developing
time-variant, non-linear models of these specific systems.
Overall, data from this first feasibility study indicates
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that a linearised model for individual patients, patient
populations andmachine sets can be calculated which defines
a linear relationship between measured arterial line pres-
sure and measured brachial artery pressure. The feasibil-
ity study thus confirms that it is practically possible to
estimate brachial BP continuously and non-invasively dur-
ing the period of a dialysis session in a clinical setting
with measurement of venous and arterial line pressure,
and occasional measurement of brachial blood pressure by
arm cuff.
V. CONCLUSION
The objective of this patient study was to answer a pressing
question in dialysis treatment, whether a method could be
developed which demonstrates the feasibility of continuous
non-invasive blood pressure monitoring, without compromis-
ing patient experience and without requiring bespoke inter-
facing to the dialysis machine, or any additional sensing to
be worn by the patient beyond current arm cuff monitoring
requirements.
An approximate mathematical model relating arterial line
pressure, blood pump flow rate and brachial pressure was
derived, which predicts a quasi-linear relationship between
arm cuff measured pressure, and corresponding pressure
measured in the arterial line near to the fistula. Interfaces,
measurement devices and a data acquisition were designed
and built to support an observational study during renal dial-
ysis treatment.
This is an early study, and we felt that a formal analysis of
external disturbances would form part of a later study. At this
time however, we can state that during each of the cases
studied here, our method provided a continuous data record
over the treatment period, whereas the data from the Finapres
Nova was restricted to 30 minute sessions with 30 minute
breaks due to discomfort. Additionally the Finapres Nova
data exhibited many instances of waveform discontinuities
and settling-time/re-calibration in the data sets.
The results from this observational study suggest that it is
feasible to derive a continuous measurement of brachial pres-
sure from continuous measurements of arterial and venous
line pressures via an empirically based and updated mathe-
matical model. Potential exists to identify a more complex
and hence more accurate parametric model.
The study presented here is critical to confirming that the
fundamentals of this approach are feasible, and the results
have confirmed that the methodology and technology has
a practical future in renal units. There are a number of
challenges following directly from this work which will be
addressed in current and future algorithmic/technological
developments and studies. In particular, iterative learning
algorithms to update the mathematical models based upon
incoming cuff BP measurements, improved mathematical
models to increase estimation accuracy, and predictive mod-
els for hypotension. Patient studies are about to start at Royal
Derby Hospital to demonstrate, analyse and improve the
continuous estimation of brachial BP in real-time for the
complete duration of dialysis treatments. Further work will
report on the outcome of these studies.
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